Avantius Launches Supplement After Study Finds Formulation Slowed Alzheimer’s Progression
This article was originally published in The Rose Sheet
Memory Health supplement was developed and is launching in the US after a small European study of Alzheimer’s patients finds improvement in patients taking a carotenoid/omega-3 combination, says marketer Avantius Group. A larger-scale, double blinded clinical study is underway in Europe.
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
Studies on supplements and brain health find no benefit in people with normal nutrient levels, says a group of 27 experts brought together by the American Association of Retired Persons. High-quality clinical studies of safety and efficacy of supplements in brain health outcomes are needed, they say.
Rising rates of Alzheimer’s disease and other cognitive conditions fuel demand for brain health supplements among consumers, with more than a third of US consumers saying they would be “very likely” to take them for memory, according to research firm Natural Marketing Institute.